Empagliflozin/Linagliptin/Metformin | m-entrepreneurship.com

Product Name :
Empagliflozin/Linagliptin/Metformin

Search keywords :
DPP

drugId :
null

Target Vo:
Dipeptidyl peptidase IV

Target Vo Short Name :
DPP4

Moa_Name:
Protein kinase AMP-activated non-catalytic subunit beta 1 activators

First Approval Country :
United States

First Approval Date Filter:
2020

Origin Company_Name :
Boehringer Ingelheim Gmbh

Active Company_Name :
Boehringer Ingelheim Gmbh

Active Indication_Name:
Diabetes Mellitus, Type 2

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Ubiquitin Rabbit pAb Protocol
LRP1 Rabbit mAb Purity & Documentation
CD133 Antibody: CD133 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 97 kDa, targeting to CD133. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts